Ceramide: a common pathway for atherosclerosis?
- PMID: 17963772
- PMCID: PMC2924671
- DOI: 10.1016/j.atherosclerosis.2007.09.018
Ceramide: a common pathway for atherosclerosis?
Abstract
Plasma sphingomyelin concentration is correlated with the development of atherosclerosis. It has been found to exist in significantly higher concentrations in aortic plaque. This appears to have clinical relevance as well as it has been shown to be an independent predictor of coronary artery disease. Ceramide, the backbone of sphingolipids, is the key component which affects atherosclerotic changes through its important second-messenger role. This paper sheds light on some of the current literature supporting the significance of ceramide with respect to its interactions with lipids, inflammatory cytokines, homocysteine and matrix metalloproteinases. Furthermore, the potential therapeutic implications of modulating ceramide concentrations are also discussed.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2924671/bin/nihms-227694-f0001.gif)
Similar articles
-
Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.Clin Sci (Lond). 2019 Mar 19;133(6):763-776. doi: 10.1042/CS20180911. Print 2019 Mar 29. Clin Sci (Lond). 2019. PMID: 30890654 Free PMC article. Review.
-
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide.J Biol Chem. 2015 Oct 23;290(43):25863-75. doi: 10.1074/jbc.M115.659110. Epub 2015 Sep 8. J Biol Chem. 2015. PMID: 26350457 Free PMC article.
-
Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study.J Am Heart Assoc. 2020 Feb 18;9(4):e012853. doi: 10.1161/JAHA.119.012853. Epub 2020 Feb 5. J Am Heart Assoc. 2020. PMID: 32019406 Free PMC article.
-
Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.J Am Heart Assoc. 2024 Jul 2;13(13):e032536. doi: 10.1161/JAHA.123.032536. Epub 2024 Jun 21. J Am Heart Assoc. 2024. PMID: 38904223 Free PMC article.
-
Involvement of sphingomyelinases in TNF signaling pathways.Chem Phys Lipids. 1999 Nov;102(1-2):157-66. doi: 10.1016/s0009-3084(99)00084-5. Chem Phys Lipids. 1999. PMID: 11001570 Review.
Cited by
-
Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease.Mol Genet Metab Rep. 2024 Apr 3;39:101077. doi: 10.1016/j.ymgmr.2024.101077. eCollection 2024 Jun. Mol Genet Metab Rep. 2024. PMID: 38595987 Free PMC article.
-
Ceramides and metabolic profiles of patients with acute coronary disease: a cross-sectional study.Front Physiol. 2023 Dec 11;14:1177765. doi: 10.3389/fphys.2023.1177765. eCollection 2023. Front Physiol. 2023. PMID: 38146506 Free PMC article.
-
Ceramides in peripheral arterial plaque lead to endothelial cell dysfunction.JVS Vasc Sci. 2023 Nov 11;4:100181. doi: 10.1016/j.jvssci.2023.100181. eCollection 2023. JVS Vasc Sci. 2023. PMID: 38077163 Free PMC article.
-
Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?Int J Mol Sci. 2023 Aug 5;24(15):12452. doi: 10.3390/ijms241512452. Int J Mol Sci. 2023. PMID: 37569827 Free PMC article.
-
Phospholipids, the Masters in the Shadows during Healing after Acute Myocardial Infarction.Int J Mol Sci. 2023 May 6;24(9):8360. doi: 10.3390/ijms24098360. Int J Mol Sci. 2023. PMID: 37176067 Free PMC article. Review.
References
-
- Jiang XC, Paultre F, Pearson TA, et al. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol. 2000;20:2614–8. - PubMed
-
- Schissel SL, Tweedie-Hardman J, Rapp JH, et al. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest. 1996;98:1455–64. - PMC - PubMed
-
- Li Z, Basterr MJ, Hailemariam TK, et al. The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis. Biochim Biophys Acta. 2005;1735:130–4. - PubMed
-
- Tabas I, Li Y, Brocia RW, et al. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. J Biol Chem. 1993;268:20419–32. - PubMed
-
- Schissel SL, Jiang X, Tweedie-Hardman J, Jeong T, et al. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem. 1998;273:2738–46. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL083471/HL/NHLBI NIH HHS/United States
- EB-002436/EB/NIBIB NIH HHS/United States
- R01 EB002436/EB/NIBIB NIH HHS/United States
- R01 HL072716/HL/NHLBI NIH HHS/United States
- HL083471/HL/NHLBI NIH HHS/United States
- R01 DE015543/DE/NIDCR NIH HHS/United States
- R01 HL065916-02/HL/NHLBI NIH HHS/United States
- R01 HL065916/HL/NHLBI NIH HHS/United States
- R01 EB002436-02/EB/NIBIB NIH HHS/United States
- HL72716/HL/NHLBI NIH HHS/United States
- HL076345/HL/NHLBI NIH HHS/United States
- AT003094/AT/NCCIH NIH HHS/United States
- R21 AT003094-01/AT/NCCIH NIH HHS/United States
- R21 AT003094/AT/NCCIH NIH HHS/United States
- R01 HL072716-02/HL/NHLBI NIH HHS/United States
- K08 HL076345/HL/NHLBI NIH HHS/United States
- R01 DE015543-02/DE/NIDCR NIH HHS/United States
- R01 HL083471-02/HL/NHLBI NIH HHS/United States
- DE15543/DE/NIDCR NIH HHS/United States
- K08 HL076345-02/HL/NHLBI NIH HHS/United States
- HL65916/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical